A study to test the effect of product in reducing dandruff

Not Applicable

Completed

• Registration Number: CTRI/2021/12/038437
• Lead Sponsor: nilever Industries Pvt Ltd

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2022-03-15
• Last Update Posted: 17 October 2022

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 153

Inclusion Criteria

1.Male or female subjects in general good health.

2.Subjects willing to give a written informed consent and agree to come for a regular follow up visit.

3.Subjects with dandruff as per dermatologistââ?¬•s assessment

4.Subjects willing to abide by and comply with the study protocol.

5.Subjects who have not participated in a similar investigation in the past three months.

6.Subjects who agree to refrain from using hair dye / hair colour during the study period.

7.Subjects willing to refrain from any type of hair treatment like perming, straightening etc. during the study duration

8.Subjects willing to refrain from any other anti-dandruff treatment/ products

Exclusion Criteria

1.Subjects who have undergone hair growth treatment within 3 months before screening into the study.

2.Subjects having any active scalp disease which may interfere in the study ââ?¬â?? dermatologistââ?¬•s judgement.

3.Subjects (male) having androgenic alopecia, male pattern baldnessââ?¬• not be included in study.

4.Subjects who have taken chemotherapy for cancer in the 6 months prior to start of the study or have a plan to do treatments during study.

5.Subjects (females) who are pregnant or lactating

6.Subjects who have had hair transplant.

7.A known history or present condition of allergic response/hypersensitivity to any cosmetic ingredients and pharmaceutical products.

8.Chronic illness which may influence the cutaneous state.

9.Subjects participating in other similar cosmetic or therapeutic trial within last three months

10.Any history of underlying uncontrolled medical illness including diabetes mellitus, hypertension, HIV, hepatitis, severe anemia, serious disorder of heart and respiratory apparatus or any other serious medical illness.

11.Subjects (males) who are having androgenic alopecia, male pattern baldness.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Significant reduction in total dandruff levelsTimepoint: 4 weeks treatment and 2 weeks regression

Secondary Outcome Measures

Name	Time	Method
Significant reduction in dandruff associated conditionsTimepoint: 4 weeks treatment and 2 weeks regression